4 Results for "

HUH-6

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HUH-6" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-120373
CAS No.: 2230044-57-0
Purity:  98.76%
Target:  

MDM-2/p53

Research Areas:  

Cancer

MB710, an aminobenzothiazole derivative, is a stabilizer of oncogenic p53 mutation Y220C. MB710 binds tightly to the Y220C pocket and stabilizes p53-Y220C, with a Kd of 4.1 μM. MB710 shows anticancer activity in p53-Y220C cell lines .
loading...
    loading...
Cat. No.: HY-U00447
CAS No.: 38275-34-2
Research Areas:  

Cancer

PK11000 is an alkylating agent, and stabilizes the DNA-binding domain of both WT and mutant p53 proteins by covalent cysteine modification without compromising DNA binding. PK11000 has anti-tumor activities .
loading...
    loading...
Cat. No.: HY-174379
Research Areas:  

Cancer

KRAS IN-44 (Compound S2C2M2) is a PDE6D degrader. KRAS IN-44 inhibits PDE6D-dependent KRAS trafficking and KRAS downstream signaling pathways. KRAS IN-44 down-regulates EGF-induced the phosphorylation of PI3K, AKT, and mTOR. KRAS IN-44 increases Apoptosis. KRAS IN-44 has antitumor activity against hepatoblastoma .
loading...
    loading...
Cat. No.: HY-182744
Target:  

MDM-2/p53

Research Areas:  

Cancer

LLQ-45 is a covalent p53 Y220C mutant protein agonist with an EC50 of 24.97 μM. LLQ-45 activates the anti-tumor function of p53 Y220C through covalent modification, restores its DNA-binding ability and enhances its thermal stability. LLQ-45 selectively inhibits the proliferation of p53 Y220C mutant tumor cells, suppresses cell growth and upregulates the expression of CDKN1A. LLQ-45 can be used in studies related to p53 Y220C mutant cancers .
loading...
    loading...